Clinical Research Therapist

Conduct Preparation, dosing and integration sessions as part of clinical trials.

2023- Present:  Compass Study Lead Research Therapist – 100 hours of supervised training in Psilocybin therapy for treatment resistant depression – COMPASS Study: A phase III, multicentre, randomised, double-blind, placebo- controlled study to investigate the efficacy, safety, and tolerability of a single administration of COMP360 in participants with treatment-resistant depression [COMP-005]

2023-2024   Clairvoyant Lead Research Therapist – 30 hours of Training. A 24 week, multi Centre, randomized, double blind, placebo controlled, parallel-group, PHASE 2 Clinical Trial to evaluate efficacy and safety of psilocybin-assisted psychotherapy in adults with alcohol use disorder (AUD). Dosed 25 participants.

Psychedelic therapy offers a transformative approach to healing by facilitating profound introspection and psychological breakthroughs.

As a therapist specializing in this field, I have witnessed firsthand its ability to catalyze deep emotional healing and promote personal growth.

Unlike traditional therapy, psychedelic-assisted sessions can help individuals access buried memories, explore complex emotions, and gain fresh perspectives on longstanding issues.

The therapeutic use of psychedelics is carefully guided, ensuring a safe and supportive environment where clients can confront challenging experiences and integrate newfound insights into their lives.

This therapeutic modality holds promise for treating conditions such as depression, PTSD, and addiction, offering a holistic path towards healing that encompasses mind, body, and spirit.



I currently work with Psilicybin & MDMA for PTSD, depression, and substance misuse. Reach out for more information